Transformation of SOE Ministry Annual Report 2020
CHAPTER 1 2345
6 7
THE ROLE OF SOE IN THE RECOVERY OF HEALTH & ECONOMIC ASPECTS
KEMISNRERAS BADASADIANTERPRESGARA
PARAMOUNT BED
ANNUAL REPORT 2020
2
SECURING & DISTRIBUTING THE COVID-19 VACCINES
Following the measures to increase the capacity of
COVID-19 treatment facilities, the Ministry of SOE took
another strategic step of procuring the COVID-19
vaccines. This was achieved through a strategic
cooperation with a global pharma company that was
developing the vaccine, while other companies were
carrying out the clinical test of the COVID-19 vaccine.
Together with the Minister of Foreign Affairs, the Ministry of
SOE was assigned by the President to lead the bilateral
negotiation with an international pharmacy company
and in a multilateral negotiation with the COVAX Facility
to secure vaccines for Indonesia.
Meanwhile, the state-owned company PT Bio Farma
(Persero) and its subsidiaries (PT Kimia Farma Tbk and PT
Indofarma Tbk) were tasked to procure the COVID-19
vaccines. By the end of 2020, a total of 155.5 million doses
of vaccines have been secured for both Government-
led vaccination and the Gotong Royong program, the
vaccination rolls out by private firms and other non-
governmental organizations, to be delivered to Indonesia
from 2020 to 2022.
PT Bio Farma (Persero), which has been manufacturing
vaccines since 1890, has increased its annual
manufacturing capacity to fill and finish the COVID-19
vaccines from 100 million to 250 million doses.
By the Coalition for Epidemic Preparedness Innovations
(CEPI), PT Bio Farma (Persero) has also been approved to
manufacture multi-platform vaccines of 100 million doses
per year to be distributed by CEPI to recipient countries.
The production will start at the end of quarter IV 2021 or
quarter I-2022.
The designation of PT Bio Farma (Persero) and its
subsidiaries to lead in vaccine production is based
on Presidential Regulation No. 99 of 2020 concerning
Vaccine Procurement and Vaccination in Response of the
COVID-19 Pandemic and Health Minister Regulation No.
28 of 2020 concerning Vaccine Procurement in Response
to the COVID-19 Pandemic.
Wisma Atlet Emergency Hospital
Wisma Atlet Emergency Hospital was one of the Ministry's
first breakthroughs in responding to the pandemic in early
2020, the early stage of COVID-19 outbreaks. Wisma Atlet,
an apartment complex designed to accommodate
athletes during trainings and competitions, were optimized
into a COVID-19 emergency hospital. The Ministry of SOE
joined hands with the Ministry of Public Works and Housing,
Ministry of Health, the Indonesian Military, the National
Disaster Management Agency, and other SOEs to prepare
four apartment towers in Wisma Atlet as the COVID-19
treatment facility in just four days.
By the inauguration day, the four towers have 1,536
treatment rooms to accommodate 4,208 patients. The
facility includes ER, ICU, and inpatient care areas. Another
tower was also prepared to accommodate health
workers and members of the COVID-19 taskforces, which
has 650 rooms with a capacity of 1,750 people.
The Ministry of SOE, SOES in the infrastructure sector,
and the Ministry of Public Works and Housing focused
on getting the infrastructure ready, while the SOE
for Indonesia Foundation and 25 SOEs, through their
corporate social responsibility funds, contributed medical
equipment, medicine supply, kitchen supplies, and
operating funds that would support the emergency
hospital during its first year. Moreover, the Ministry of
Health set up the health protocols, and the Indonesian
Military, Indonesian Police, and volunteers managed by
the COVID-19 Response Acceleration Taskforce helped
managing the traffic of operations in the hospital.
VAKSI
AMAN dan HALA
12
RESILIENCE AMIDST UNCERTAINTY
RESILIENCE AMIDST UNCERTAINTY
13View entire presentation